Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.

Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Res. 2012 May 15; 72(10):2522-32.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.